These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4605835)

  • 21. [Current trends in phosphotherapy. IV. Treatment of oxalic lithiasis].
    Eisinger J; d' Omezon Y; Recordier AM
    Mars Med; 1971; 108(9):605-8. PubMed ID: 5120435
    [No Abstract]   [Full Text] [Related]  

  • 22. [Recent data on the urinary excretion of oxalic acid in oxalic renal lithiasis].
    Thomas J; Melon JM; Thomas E; Steg A; Desgrez P; Aboulker P
    Ann Urol (Paris); 1972 Feb; 6(1):31-3. PubMed ID: 5012700
    [No Abstract]   [Full Text] [Related]  

  • 23. [Oxalosis].
    Broyer M; Berger R
    Presse Med (1893); 1968 Dec; 76(50):2395-6. PubMed ID: 5732646
    [No Abstract]   [Full Text] [Related]  

  • 24. [Correction of electrolyte imbalance by treatment with covalitin in renoureteral lithiasis of the oxalic type].
    Poenaru A; Covaliu T; Subinschi G; Marcu E
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(5):471-6. PubMed ID: 6143368
    [No Abstract]   [Full Text] [Related]  

  • 25. [Oxalic lithiasis and disorder of uric acid metabolism].
    Mugler A
    J Urol Nephrol (Paris); 1970 Dec; 76(12):423-34. PubMed ID: 5522994
    [No Abstract]   [Full Text] [Related]  

  • 26. [The primary oxalosis].
    Albert FW
    Med Klin; 1975 Jul; 70(28-29):1223-6. PubMed ID: 1177791
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of primary hyperoxaluria.
    Smith LH; Williams HE
    Mod Treat; 1967 May; 4(3):522-30. PubMed ID: 6045805
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical importance of oxalic acid.
    Bourke E; Costello J
    Ir Med J; 1975 Feb; 68(4):93-6. PubMed ID: 1112694
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic studies in hypercalciuric acid hyperoxaluric children with kidney stones.
    Kepozou L; Vretos C; Lapatsanis P
    Scand J Urol Nephrol Suppl; 1980; 53():221-4. PubMed ID: 6937999
    [No Abstract]   [Full Text] [Related]  

  • 30. [The relationship between the basic substance and mineral disorders in metabolic urinary calculi disease].
    Berariu T; Scheau M; Ticlete V; Hoinărescu E
    Z Urol Nephrol; 1966 Nov; 59(11):801-3. PubMed ID: 5998479
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxalic acid, calcium, and phosphorus in the renal papilla of normal and stone forming rats.
    Wright RJ; Hodgkinson A
    Invest Urol; 1972 Mar; 9(5):369-75. PubMed ID: 5016022
    [No Abstract]   [Full Text] [Related]  

  • 32. [Does vitamin E protect against experimental lithiasis?].
    Sakly A; Achour A; Zouaghi H
    Ann Urol (Paris); 1994; 28(5):265-7. PubMed ID: 7825984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental lithogenesis using glyoxylic acid].
    Miján Ortiz JL; Zuluaga Gómez A; Martínez Torres JL; Navarro Sánchez A
    Arch Esp Urol; 1987; 40(6):412-5. PubMed ID: 3674993
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of a 5-year treatment program in patients with hyperoxaluric stones.
    Pinto B; Ruiz-Marcellán FJ; Bernshtam J
    J Urol; 1983 Nov; 130(5):943-5. PubMed ID: 6632105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of magnesium on oxalo-calcic experimental lithiasis developed with ethyleneglycol].
    Minón Cifuentes JL; Castrillo Garcia JM
    Rev Clin Esp; 1977 Oct; 147(1):11-4. PubMed ID: 22107
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of medical treatment of renal lithiasis 5 years later].
    Ruiz Marcellán FJ; Bernshtam J; Pinto B
    Actas Urol Esp; 1982; 6(5):273-6. PubMed ID: 7158456
    [No Abstract]   [Full Text] [Related]  

  • 37. [Metabolic changes in staghorn lithiasis].
    Ruiz Marcellán FJ; Bernshtam Ballester J; Ibarz Servio L; Pinto Mateos B
    Actas Urol Esp; 1982; 6(4):207-10. PubMed ID: 7136888
    [No Abstract]   [Full Text] [Related]  

  • 38. [pH, titrable acidity and urinary buffer power in oxalic lithiasis, gout and uric lithiasis].
    Thomas J; Thomas E; Rabussier H; Desgrez P
    J Urol Nephrol (Paris); 1968 Sep; 74(9):690-3. PubMed ID: 5718186
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of oxalate and phosphate lithiasis by alanine.
    Chow FH; Hamar DW; Udall RH
    Invest Urol; 1974 Jul; 12(1):50-3. PubMed ID: 4835490
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of DL alpha-lipoic acid in glyoxylate-induced acute lithiasis.
    Jayanthi S; Saravanan N; Varalakshmi P
    Pharmacol Res; 1994; 30(3):281-8. PubMed ID: 7862622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.